Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis
Authors
Affiliations
Epitope mapping the specific residues of an antibody/antigen interaction can be used to support mechanistic interpretation, antibody optimization, and epitope novelty assessment. Thus, there is a strong need for mapping methods, particularly integrative ones. Here, we report the identification of an energetic epitope by determining the interfacial hot-spot that dominates the binding affinity for an anti-interleukin-23 (anti-IL-23) antibody by using the complementary approaches of hydrogen/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), alanine shave mutagenesis, and binding analytics. Five peptide regions on IL-23 with reduced backbone amide solvent accessibility upon antibody binding were identified by HDX-MS, and five different peptides over the same three regions were identified by FPOP. In addition, FPOP analysis at the residue level reveals potentially key interacting residues. Mutants with 3-5 residues changed to alanine have no measurable differences from wild-type IL-23 except for binding of and signaling blockade by the 7B7 anti-IL-23 antibody. The M5 IL-23 mutant differs from wild-type by five alanine substitutions and represents the dominant energetic epitope of 7B7. M5 shows a dramatic decrease in binding to BMS-986010 (which contains the 7B7 Fab, where Fab is fragment antigen-binding region of an antibody), yet it maintains functional activity, binding to p40 and p19 specific reagents, and maintains biophysical properties similar to wild-type IL-23 (monomeric state, thermal stability, and secondary structural features).
Shortt R, Pino L, Chea E, Ramirez C, Polasky D, Nesvizhskii A J Am Soc Mass Spectrom. 2024; 35(12):3301-3307.
PMID: 39356573 PMC: 11622367. DOI: 10.1021/jasms.4c00196.
Shah A, Batabyal D, Qiu D, Cui W, Harrahy J, Ivanov A J Pharm Anal. 2024; 14(8):100966.
PMID: 39263356 PMC: 11388688. DOI: 10.1016/j.jpha.2024.100966.
Lin Y, Moyle A, Beaumont V, Liu L, Polleck S, Liu H Anal Chem. 2023; 95(46):16840-16849.
PMID: 37933954 PMC: 10909587. DOI: 10.1021/acs.analchem.3c02422.
Hydrogen Deuterium Exchange and other Mass Spectrometry-based Approaches for Epitope Mapping.
Jethva P, Gross M Front Anal Sci. 2023; 3.
PMID: 37746528 PMC: 10512744. DOI: 10.3389/frans.2023.1118749.
Ralston C, Sharp J Antibodies (Basel). 2022; 11(4).
PMID: 36412837 PMC: 9680451. DOI: 10.3390/antib11040071.